GLP-1 receptor agonists show promise in treating substance use disorders
A systematic review reveals that GLP-1 receptor agonists may help reduce certain substance use disorders, but findings are inconsistent due ...
A systematic review reveals that GLP-1 receptor agonists may help reduce certain substance use disorders, but findings are inconsistent due ...
In this interview, we explore global and local efforts to combat viral hepatitis with Lindsey Hiebert, Deputy Director of the ...
A new study, out now in Drug and Alcohol Dependence, that details trends among psychiatric hospitalizations between 2015-2019 finds that ...
A recent study published in the journal Nutrients investigates the association between coffee consumption and polycystic ovarian syndrome (PCOS) in ...
Smoking may be among the most important lifestyle factors affecting how quickly our cognitive skills decline as we age, suggests ...
Stress during childhood is associated with earlier substance use in male and female adolescents, according to a study presented Saturday ...
The first U.S. trial of varenicline for e-cigarette cessation shows promising results and warrants larger-scale trials, the researchers say. Researchers ...
In a recent study published in The Lancet Digital Health, a group of researchers assessed the long-term effectiveness of four ...
Depression and cardiovascular disease (CVD) are serious concerns for public health. Approximately 280 million people worldwide have depression, while 620 million ...
Public health experts are calling for a ban on alcohol industry-funded education programmes in UK universities and schools, which they ...
Sepoy.net is a perfect place for people who want daily updates on news related to business, technology, entertainment, health, cryptocurrency etc.
Contact: hello@sepoy.net
© 2023 Sepoy.net